Helen B Pearson1, Pedro A Perez-Mancera, Lukas E Dow
1Cell Cycle and Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
View abstract on PubMed
Loss of Scrib, a key polarity regulator, drives prostate cancer in mice by disrupting cellular homeostasis and activating the MAPK cascade. This finding highlights the polarity network as a potential target for prostate cancer therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: